1.18

1.72% 0.02

X T L Biopharmaceuticals Ltd Adr (XTLB)

Overview News Price History Discussions Forecast Stock Split

X T L Biopharmaceuticals Ltd Adr stock is traded at $1.18, with a volume of 4,878. It is up +1.72% in the last 24 hours and down -16.31% over the past month. XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

Previous Close:

$1.16

Open:

$1.2

24h Volume:

4,878

Relative Volume:

0.57

Market Cap:

$1.04B

Revenue:

Net Income/Loss:

$-2.25M

P/E Ratio:

-2.95

EPS:

-0.4

Net Cash Flow:

1W Performance:

+6.31%

1M Performance:

-16.31%

6M Performance:

-37.23%

1Y Performance:

-55.47%

1-Day Range:

$1.18

$1.25

1-Week Range:

$1.11

$1.25

52-Week Range:

$0.9208

$3.05

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile

Name

X T L Biopharmaceuticals Ltd Adr

Sector

Healthcare (1177)

Industry

Biotechnology (671)

Phone

Address

Employee

Twitter

@xtlbio

Next Earnings Date

2024-05-24

Latest SEC Filings

XTLB's Discussions on Twitter

Compare XTLB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XTLB X T L Biopharmaceuticals Ltd Adr	1.18	9.52M	0	-2.25M	0	-0.40
ONC Beone Medicines Ltd Adr	245.77	25.81B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	443.42	111.46B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.32	40.37M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	80.81	6.19B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	493.38	64.44B	14.09B	4.50B	2.96B	39.28